Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

Nobuhiro Nishio, Yoshiyuki Takahashi, Haruhiko Ohashi, Sayoko Doisaki, Hideki Muramatsu, Asahito Hama, Akira Shimada, Hiroshi Yagasaki, Seiji Kojima

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with a myeloablative regimen were disappointing, we used a reduced-intensity conditioning regimen for two patients with classic DC, and one patient with cryptic DC who harbored the TERT mutation. Graft sources included two mismatched-related bone marrow (BM) donors and one unrelated BM donor. Successful engraftment was achieved with few regimen-related toxicities in all patients. They were alive 10, 66, and 72 months after transplantation, respectively. Long-term follow-up is crucial to determine the late effects of our conditioning regimen.

Original languageEnglish
Pages (from-to)161-166
Number of pages6
JournalPediatric Transplantation
Volume15
Issue number2
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Fingerprint

Dyskeratosis Congenita
Hematopoietic Stem Cell Transplantation
Tissue Donors
Bone Marrow
Malformed Nails
Oral Leukoplakia
Skin Pigmentation
Unrelated Donors
Cause of Death
Transplantation
Transplants
Mutation

Keywords

  • dyskeratosis congenita
  • non-myeloablative hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. / Nishio, Nobuhiro; Takahashi, Yoshiyuki; Ohashi, Haruhiko; Doisaki, Sayoko; Muramatsu, Hideki; Hama, Asahito; Shimada, Akira; Yagasaki, Hiroshi; Kojima, Seiji.

In: Pediatric Transplantation, Vol. 15, No. 2, 03.2011, p. 161-166.

Research output: Contribution to journalArticle

Nishio, Nobuhiro ; Takahashi, Yoshiyuki ; Ohashi, Haruhiko ; Doisaki, Sayoko ; Muramatsu, Hideki ; Hama, Asahito ; Shimada, Akira ; Yagasaki, Hiroshi ; Kojima, Seiji. / Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. In: Pediatric Transplantation. 2011 ; Vol. 15, No. 2. pp. 161-166.
@article{5e978628626b4755b0bd795b709a5c1f,
title = "Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita",
abstract = "DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with a myeloablative regimen were disappointing, we used a reduced-intensity conditioning regimen for two patients with classic DC, and one patient with cryptic DC who harbored the TERT mutation. Graft sources included two mismatched-related bone marrow (BM) donors and one unrelated BM donor. Successful engraftment was achieved with few regimen-related toxicities in all patients. They were alive 10, 66, and 72 months after transplantation, respectively. Long-term follow-up is crucial to determine the late effects of our conditioning regimen.",
keywords = "dyskeratosis congenita, non-myeloablative hematopoietic stem cell transplantation",
author = "Nobuhiro Nishio and Yoshiyuki Takahashi and Haruhiko Ohashi and Sayoko Doisaki and Hideki Muramatsu and Asahito Hama and Akira Shimada and Hiroshi Yagasaki and Seiji Kojima",
year = "2011",
month = "3",
doi = "10.1111/j.1399-3046.2010.01431.x",
language = "English",
volume = "15",
pages = "161--166",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

AU - Nishio, Nobuhiro

AU - Takahashi, Yoshiyuki

AU - Ohashi, Haruhiko

AU - Doisaki, Sayoko

AU - Muramatsu, Hideki

AU - Hama, Asahito

AU - Shimada, Akira

AU - Yagasaki, Hiroshi

AU - Kojima, Seiji

PY - 2011/3

Y1 - 2011/3

N2 - DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with a myeloablative regimen were disappointing, we used a reduced-intensity conditioning regimen for two patients with classic DC, and one patient with cryptic DC who harbored the TERT mutation. Graft sources included two mismatched-related bone marrow (BM) donors and one unrelated BM donor. Successful engraftment was achieved with few regimen-related toxicities in all patients. They were alive 10, 66, and 72 months after transplantation, respectively. Long-term follow-up is crucial to determine the late effects of our conditioning regimen.

AB - DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with a myeloablative regimen were disappointing, we used a reduced-intensity conditioning regimen for two patients with classic DC, and one patient with cryptic DC who harbored the TERT mutation. Graft sources included two mismatched-related bone marrow (BM) donors and one unrelated BM donor. Successful engraftment was achieved with few regimen-related toxicities in all patients. They were alive 10, 66, and 72 months after transplantation, respectively. Long-term follow-up is crucial to determine the late effects of our conditioning regimen.

KW - dyskeratosis congenita

KW - non-myeloablative hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=79951633240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951633240&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2010.01431.x

DO - 10.1111/j.1399-3046.2010.01431.x

M3 - Article

C2 - 21176016

AN - SCOPUS:79951633240

VL - 15

SP - 161

EP - 166

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 2

ER -